MedTrace Logo

Standardized Protocol of Surgery and Radiation for Patients With Brain Metastases in Relapsed Neuroblastoma

NCT03406273 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2023-09-28

No results posted yet for this study

Summary

HITC001 is a single institution study to evaluate the efficacy of using a standardized protocol of surgery and radiation for patients with brain metastases in relapsed neuroblastoma.

Conditions

  • Relapsed Neuroblastoma

Interventions

RADIATION

Cerebral Spinal (CS) radiation

Surgery plus Cerebral Spinal (CS) radiation

RADIATION

Focal radiotherapy (SRS)

Surgery plus focal radiotherapy (stereotactic radiosurgery to the tumor bed \[SRS\])

Sponsors & Collaborators

  • Giselle Sholler

    lead OTHER

Principal Investigators

  • Kaveh Asadi-Moghaddam, MD · Spectrum Health Hospitals

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Max Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-31
Primary Completion
2017-05-01
Completion
2019-12-11

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03406273 on ClinicalTrials.gov